CEO Marc Vandelaer reveals why the Luxembourg biobank IBBL is more than a traditional biobank and how, despite the short time since its inception in 2010, it has begun to receive recognition as a leader within the biobanking industry and a valued bioservice provider.
IBBL (Integrated BioBank of Luxembourg) has been described as ‘more than a traditional biobank’ – with that in mind, could you please introduce IBBL?
As an integrated research infrastructure, we provide all of these bioservices: collection, processing, analysis and storage of biological samples and associated data
